Profilo
Paula G.
O’Connor is Chief Medical Officer at Nurix Therapeutics, Inc. since 2024.
Formerly, Dr. O’Connor was Senior Vice President-Clinical Development at Protagonist Therapeutics, Inc. Education includes a doctorate from Stanford University School of Medicine and an undergraduate degree from Yale University.
Posizioni attive di Paula O’Connor
| Società | Posizione | Inizio |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2022 |
Precedenti posizioni note di Paula O’Connor
| Società | Posizione | Fine |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2022 |
Formazione di Paula O’Connor
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















